Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
复制标题
作为用于 PET 或 SPECT 脑成像的血清素 5-HT2A 配体的卤化二苯基哌啶的合成、受体效力和选择性。
DOI:
10.1021/jm0200411
复制
发表时间:
2002
影响因子:
7.3
通讯作者:
Baldwin,RonaldM
中科院分区:
文献类型:
--
作者:
Fu,Xing;Tan,Ping-Zhong;Kula,NoraS;Baldessarini,Ross;Tamagnan,Gilles;Innis,RobertB;Baldwin,RonaldM
A series of 4‘-substituted phenyl-4-piperidinylmethanol and benzoyl-4-piperidine derivatives was synthesized as potential novel serotonin 5-HT2Areceptor ligands that can be radiolabeled for in vivo brain imaging. Compounds were prepared by alkylation of 4-substituted benzoyl-4-piperidine with an iodo- or fluoro-substituted phenylalkyl halide followed by reduction with sodium borohydride. Potency of novel compounds was determined by in vitro radioreceptor affinity assays selective for serotonin 5-HT2Areceptors. Potent compounds were further evaluated for selectivity at serotonin-2A versus 2C, 6, and 7, as well as dopamine D2and adrenergic α1and α2receptors. The novel compound (4-fluorophenyl)-(1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl])methanol was particularly promising with high 5-HT2Apotency (Ki= 1.63 nM) and >300-fold selectivity over other 5-HT receptor types.